These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 26451067)

  • 1. Serum Survivin Levels and Outcome of Chemotherapy in Patients with Malignant Mesothelioma.
    Goričar K; Kovač V; Franko A; Dodič-Fikfak M; Dolžan V
    Dis Markers; 2015; 2015():316739. PubMed ID: 26451067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is serum survivin expression a predictive biomarker in locally advanced gastric cancer patients treated with neoadjuvant chemotherapy?
    Bozkaya Y; Özdemir NY; Sezer S; Köstek O; Demirci NS; Yazıcı O; Erdem GU; Eren T; Zengin N
    Cancer Biomark; 2018; 22(1):143-149. PubMed ID: 29562501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survivin expression and serum levels in pancreatic cancer.
    Dong H; Qian D; Wang Y; Meng L; Chen D; Ji X; Feng W
    World J Surg Oncol; 2015 May; 13():189. PubMed ID: 26016480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of serum levels of angiopoietin-2 and survivin biomarkers in non-small cell lung cancer.
    Fawzy A; Gaafar R; Kasem F; Ali SS; Elshafei M; Eldeib M
    J Egypt Natl Canc Inst; 2012 Mar; 24(1):41-5. PubMed ID: 23587231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble mesothelin, megakaryocyte potentiating factor, and osteopontin as markers of patient response and outcome in mesothelioma.
    Hollevoet K; Nackaerts K; Gosselin R; De Wever W; Bosquée L; De Vuyst P; Germonpré P; Kellen E; Legrand C; Kishi Y; Delanghe JR; van Meerbeeck JP
    J Thorac Oncol; 2011 Nov; 6(11):1930-7. PubMed ID: 21841505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is survivin expression prognostic or predictive in malignant pleural mesothelioma?
    Hmeljak J; Erčulj N; Dolžan V; Pižem J; Kern I; Kovač V; Cemažar M; Cör A
    Virchows Arch; 2013 Mar; 462(3):315-21. PubMed ID: 23358691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of serum survivin level in early diagnosis of cancer.
    Gunaldi M; Isiksacan N; Kocoglu H; Okuturlar Y; Gunaldi O; Topcu TO; Karabulut M
    J Cancer Res Ther; 2018; 14(3):570-573. PubMed ID: 29893319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of
    Kafadar D; Yaylim I; Kafadar AM; Cacina C; Ergen A; Kaynar MY; Isbir T
    Anticancer Res; 2018 Oct; 38(10):5991-5998. PubMed ID: 30275230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of pretreatment VEGF, survivin, and Smac/DIABLO serum levels in patients with serous ovarian carcinoma.
    Dobrzycka B; Mackowiak-Matejczyk B; Terlikowska KM; Kulesza-Bronczyk B; Kinalski M; Terlikowski SJ
    Tumour Biol; 2015 Jun; 36(6):4157-65. PubMed ID: 25577253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of high levels of survivin and transforming growth factor beta-1 proteins in aqueous humor and serum of retinoblastoma patients.
    Shehata HH; Abou Ghalia AH; Elsayed EK; Ahmed Said AM; Mahmoud SS
    J AAPOS; 2016 Oct; 20(5):444.e1-444.e9. PubMed ID: 27663628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum levels of apoptosis biomarkers, survivin and TNF-alpha in nonsmall cell lung cancer.
    Derin D; Soydinç HO; Guney N; Tas F; Camlica H; Duranyildiz D; Yasasever V; Topuz E
    Lung Cancer; 2008 Feb; 59(2):240-5. PubMed ID: 17875341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prognosis related clinical and molecular factors in malignant pleural mesothelioma].
    Wang YY; Zhang H; Bai H; Wang SH; Wu MN; An TT; Zhao J; Zhuo ML; Duan JC; Wang ZJ; Wang J
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Mar; 36(3):162-8. PubMed ID: 23856136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of serum vascular endothelial growth factor in malignant pleural mesothelioma.
    Yasumitsu A; Tabata C; Tabata R; Hirayama N; Murakami A; Yamada S; Terada T; Iida S; Tamura K; Fukuoka K; Kuribayashi K; Nakano T
    J Thorac Oncol; 2010 Apr; 5(4):479-83. PubMed ID: 20357617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitor of apoptosis proteins are regulated by tumour necrosis factor-alpha in malignant pleural mesothelioma.
    Gordon GJ; Mani M; Mukhopadhyay L; Dong L; Yeap BY; Sugarbaker DJ; Bueno R
    J Pathol; 2007 Mar; 211(4):439-46. PubMed ID: 17253597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of serum survivin protein in diagnosis and prognosis of gallbladder cancer: a comparative study.
    Nigam J; Chandra A; Kazmi HR; Singh A; Gupta V; Parmar D; Srivastava MK
    Med Oncol; 2014 Sep; 31(9):167. PubMed ID: 25129311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of survivin, X-linked inhibitor of apoptosis protein and second mitochondria-derived activator of caspases expression in advanced non-small-cell lung cancer patients.
    Chen P; Li J; Ge LP; Dai CH; Li XQ
    Respirology; 2010 Apr; 15(3):501-9. PubMed ID: 20210890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ERC/mesothelin as a marker for chemotherapeutic response in patients with mesothelioma.
    Tajima K; Hirama M; Shiomi K; Ishiwata T; Yoshioka M; Iwase A; Iwakami S; Yamazaki M; Toba M; Tobino K; Sugano K; Ichikawa M; Hagiwara Y; Takahashi K; Hino O
    Anticancer Res; 2008; 28(6B):3933-6. PubMed ID: 19192652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum soluble mesothelin concentrations in malignant pleural mesothelioma: relationship to tumor volume, clinical stage and changes in tumor burden.
    Creaney J; Francis RJ; Dick IM; Musk AW; Robinson BW; Byrne MJ; Nowak AK
    Clin Cancer Res; 2011 Mar; 17(5):1181-9. PubMed ID: 21177406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A biomarker profile for predicting efficacy of cisplatin-vinorelbine therapy in malignant pleural mesothelioma.
    Zimling ZG; Sørensen JB; Gerds TA; Bech C; Andersen CB; Santoni-Rugiu E
    Cancer Chemother Pharmacol; 2012 Nov; 70(5):743-54. PubMed ID: 22960937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum and urine survivin levels in breast cancer.
    Guney N; Soydine HO; Derin D; Tas F; Camlica H; Duranyildiz D; Yasasever V; Topuz E
    Med Oncol; 2006; 23(3):335-9. PubMed ID: 17018890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.